Will ACMR’s Revenue Momentum Outweigh Profit Pressure as Earnings Near?

• Shares of ACM Research recently declined following a strong month, as investors focus on the company’s upcoming earnings announcement scheduled for November 5, 2025, with expectations for a 25.4% decline in EPS but a 23.07% increase in quarterly revenue.
• Recent analyst estimate revisions indicate generally favorable views on business health and profitability, despite EPS headwinds, suggesting shifting market sentiment ahead of the results.
• We’ll explore how anticipation over potential revenue growth for the upcoming quarter could influence ACM Research’s broader investment narrative.

Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 37 best rare earth metal stocks of the very few that mine this essential strategic resource.

ACM Research Investment Narrative Recap

To be a shareholder in ACM Research, one needs confidence in the company’s ability to capture revenue growth from advanced semiconductor manufacturing, especially as global digitalization and AI adoption gather pace. The recent 2.16% share dip after a strong run does little to materially shift the most important short-term catalyst: the company’s upcoming earnings, where a potential revenue jump is in focus. However, risks tied to reliance on China’s semiconductor market and ongoing export controls remain central for investors.

Of the recent announcements, ACM Research’s shipment of its new Ultra Lith KrF Track System to a leading Chinese customer stands out. This development ties closely to the anticipated revenue growth in the next quarter and suggests the company is strengthening its core business in China, directly connected to the short-term results investors are watching.

By contrast, ongoing regulatory risks related to U.S.-China export controls could have a larger impact on ACM Research than many investors realize...

Read the full narrative on ACM Research (it's free!)

ACM Research's outlook anticipates $1.4 billion in revenue and $189.6 million in earnings by 2028. This is based on a projected annual revenue growth rate of 19.1% and an increase in earnings of $77.5 million from the current $112.1 million.

Uncover how ACM Research's forecasts yield a $42.04 fair value, in line with its current price.

Exploring Other Perspectives

Five fair value estimates from the Simply Wall St Community range from US$29.96 to US$42.04, reflecting a broad spectrum of investor expectations. Meanwhile, reliance on China’s semiconductor market remains a key factor with significant implications for future performance.

Explore 5 other fair value estimates on ACM Research - why the stock might be worth as much as $42.04!

Build Your Own ACM Research Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your ACM Research research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.
• Our free ACM Research research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate ACM Research's overall financial health at a glance.

Contemplating Other Strategies?

Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:

• We've found 17 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.
• AI is about to change healthcare. These 33 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Uncover the next big thing with financially sound penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com